IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,330 | +9.6% | 242,037 | +21.2% | 0.02% | +15.0% |
| Q2 2023 | $2,125 | +46.2% | 199,745 | +44.6% | 0.02% | +11.1% |
| Q1 2023 | $1,453 | -63.6% | 138,167 | -57.1% | 0.02% | -67.9% |
| Q4 2022 | $3,987 | -99.9% | 321,829 | -52.5% | 0.06% | -26.3% |
| Q3 2022 | $7,016,000 | +912.4% | 677,233 | +1175.9% | 0.08% | +1800.0% |
| Q3 2021 | $693,000 | -32.0% | 53,077 | -33.0% | 0.00% | -55.6% |
| Q2 2021 | $1,019,000 | +495.9% | 79,184 | +424.9% | 0.01% | +200.0% |
| Q4 2020 | $171,000 | +58.3% | 15,086 | +19.2% | 0.00% | -40.0% |
| Q3 2019 | $108,000 | – | 12,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |